aluates Reports

$ 0.0

Automative

Global Ankylosing Spondylitis Treatment Drug Market Research Report 2025

Published Date: July 2025

Report Code: QYRE-Auto-12Y8293

Global Ankylosing Spondylitis Treatment Drug Market Insights Forecast to 2028

BUY CHAPTERS

Global Ankylosing Spondylitis Treatment Drug Market Research Report 2025

Code: QYRE-Auto-12Y8293

Report

July 2025

Pages:93

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abbott

Merck

Eisai Co Ltd

Novartis

Pfizer Inc

Johson & Johson

Abbive

UCB

Amgen Inc

Takeda

Mitsubishi Tanabe

Hisun Pharm

Guojian Pharmaceutical

Bio-Thera Solutions

Maibo Pharma

Celgen Pharm

Ankylosing Spondylitis Treatment Drug Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Ankylosing Spondylitis Treatment Drug Market

The global market for Ankylosing Spondylitis Treatment Drug was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Ankylosing Spondylitis Treatment Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Ankylosing Spondylitis Treatment Drug.

The Ankylosing Spondylitis Treatment Drug market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Ankylosing Spondylitis Treatment Drug market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Ankylosing Spondylitis Treatment Drug companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Ankylosing Spondylitis Treatment Drug Market Report

Report Metric	Details
Report Name	Ankylosing Spondylitis Treatment Drug Market
CAGR	5%
Segment by Type	Non-steroidal Anti-inflammatory Drugs Inhibitor
Segment by Application	Hospital Pharmacy Retail Pharmacy Online Pharmacy Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbott, Merck, Eisai, Novartis, Pfizer, Johson & Johson, Abbive, UCB, Amgen, Takeda, Mitsubishi Tanabe, Hisun Pharm, Guojian Pharmaceutical, Bio-Thera Solutions, Maibo Pharma, Celgen Pharm
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Ankylosing Spondylitis Treatment Drug company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Ankylosing Spondylitis Treatment Drug Market report?

Ans: The main players in the Ankylosing Spondylitis Treatment Drug Market are Abbott, Merck, Eisai, Novartis, Pfizer, Johson & Johson, Abbive, UCB, Amgen, Takeda, Mitsubishi Tanabe, Hisun Pharm, Guojian Pharmaceutical, Bio-Thera Solutions, Maibo Pharma, Celgen Pharm

What are the Application segmentation covered in the Ankylosing Spondylitis Treatment Drug Market report?

Ans: The Applications covered in the Ankylosing Spondylitis Treatment Drug Market report are Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other

What are the Type segmentation covered in the Ankylosing Spondylitis Treatment Drug Market report?

Ans: The Types covered in the Ankylosing Spondylitis Treatment Drug Market report are Non-steroidal Anti-inflammatory Drugs, Inhibitor

Recommended Reports

Rheumatic Disease Treatments

Pain & Musculoskeletal

Autoimmune & Inflammatory

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Ankylosing Spondylitis Treatment Drug Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Non-steroidal Anti-inflammatory Drugs

1.2.3 Inhibitor

1.3 Market by Application

1.3.1 Global Ankylosing Spondylitis Treatment Drug Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospital Pharmacy

1.3.3 Retail Pharmacy

1.3.4 Online Pharmacy

1.3.5 Other

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Ankylosing Spondylitis Treatment Drug Market Perspective (2020-2031)

2.2 Global Ankylosing Spondylitis Treatment Drug Growth Trends by Region

2.2.1 Global Ankylosing Spondylitis Treatment Drug Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Ankylosing Spondylitis Treatment Drug Historic Market Size by Region (2020-2025)

2.2.3 Ankylosing Spondylitis Treatment Drug Forecasted Market Size by Region (2026-2031)

2.3 Ankylosing Spondylitis Treatment Drug Market Dynamics

2.3.1 Ankylosing Spondylitis Treatment Drug Industry Trends

2.3.2 Ankylosing Spondylitis Treatment Drug Market Drivers

2.3.3 Ankylosing Spondylitis Treatment Drug Market Challenges

2.3.4 Ankylosing Spondylitis Treatment Drug Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Ankylosing Spondylitis Treatment Drug Players by Revenue

3.1.1 Global Top Ankylosing Spondylitis Treatment Drug Players by Revenue (2020-2025)

3.1.2 Global Ankylosing Spondylitis Treatment Drug Revenue Market Share by Players (2020-2025)

3.2 Global Ankylosing Spondylitis Treatment Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Ankylosing Spondylitis Treatment Drug Revenue

3.4 Global Ankylosing Spondylitis Treatment Drug Market Concentration Ratio

3.4.1 Global Ankylosing Spondylitis Treatment Drug Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Ankylosing Spondylitis Treatment Drug Revenue in 2024

3.5 Global Key Players of Ankylosing Spondylitis Treatment Drug Head office and Area Served

3.6 Global Key Players of Ankylosing Spondylitis Treatment Drug, Product and Application

3.7 Global Key Players of Ankylosing Spondylitis Treatment Drug, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Ankylosing Spondylitis Treatment Drug Breakdown Data by Type

4.1 Global Ankylosing Spondylitis Treatment Drug Historic Market Size by Type (2020-2025)

4.2 Global Ankylosing Spondylitis Treatment Drug Forecasted Market Size by Type (2026-2031)

5 Ankylosing Spondylitis Treatment Drug Breakdown Data by Application

5.1 Global Ankylosing Spondylitis Treatment Drug Historic Market Size by Application (2020-2025)

5.2 Global Ankylosing Spondylitis Treatment Drug Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Ankylosing Spondylitis Treatment Drug Market Size (2020-2031)

6.2 North America Ankylosing Spondylitis Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Ankylosing Spondylitis Treatment Drug Market Size by Country (2020-2025)

6.4 North America Ankylosing Spondylitis Treatment Drug Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Ankylosing Spondylitis Treatment Drug Market Size (2020-2031)

7.2 Europe Ankylosing Spondylitis Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Ankylosing Spondylitis Treatment Drug Market Size by Country (2020-2025)

7.4 Europe Ankylosing Spondylitis Treatment Drug Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Ankylosing Spondylitis Treatment Drug Market Size (2020-2031)

8.2 Asia-Pacific Ankylosing Spondylitis Treatment Drug Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Ankylosing Spondylitis Treatment Drug Market Size by Region (2020-2025)

8.4 Asia-Pacific Ankylosing Spondylitis Treatment Drug Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Ankylosing Spondylitis Treatment Drug Market Size (2020-2031)

9.2 Latin America Ankylosing Spondylitis Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Ankylosing Spondylitis Treatment Drug Market Size by Country (2020-2025)

9.4 Latin America Ankylosing Spondylitis Treatment Drug Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size (2020-2031)

10.2 Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size by Country (2020-2025)

10.4 Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbott

11.1.1 Abbott Company Details

11.1.2 Abbott Business Overview

11.1.3 Abbott Ankylosing Spondylitis Treatment Drug Introduction

11.1.4 Abbott Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

11.1.5 Abbott Recent Development

11.2 Merck

11.2.1 Merck Company Details

11.2.2 Merck Business Overview

11.2.3 Merck Ankylosing Spondylitis Treatment Drug Introduction

11.2.4 Merck Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

11.2.5 Merck Recent Development

11.3 Eisai

11.3.1 Eisai Company Details

11.3.2 Eisai Business Overview

11.3.3 Eisai Ankylosing Spondylitis Treatment Drug Introduction

11.3.4 Eisai Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

11.3.5 Eisai Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Ankylosing Spondylitis Treatment Drug Introduction

11.4.4 Novartis Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

11.4.5 Novartis Recent Development

11.5 Pfizer

11.5.1 Pfizer Company Details

11.5.2 Pfizer Business Overview

11.5.3 Pfizer Ankylosing Spondylitis Treatment Drug Introduction

11.5.4 Pfizer Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

11.5.5 Pfizer Recent Development

11.6 Johson & Johson

11.6.1 Johson & Johson Company Details

11.6.2 Johson & Johson Business Overview

11.6.3 Johson & Johson Ankylosing Spondylitis Treatment Drug Introduction

11.6.4 Johson & Johson Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

11.6.5 Johson & Johson Recent Development

11.7 Abbive

11.7.1 Abbive Company Details

11.7.2 Abbive Business Overview

11.7.3 Abbive Ankylosing Spondylitis Treatment Drug Introduction

11.7.4 Abbive Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

11.7.5 Abbive Recent Development

11.8 UCB

11.8.1 UCB Company Details

11.8.2 UCB Business Overview

11.8.3 UCB Ankylosing Spondylitis Treatment Drug Introduction

11.8.4 UCB Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

11.8.5 UCB Recent Development

11.9 Amgen

11.9.1 Amgen Company Details

11.9.2 Amgen Business Overview

11.9.3 Amgen Ankylosing Spondylitis Treatment Drug Introduction

11.9.4 Amgen Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

11.9.5 Amgen Recent Development

11.10 Takeda

11.10.1 Takeda Company Details

11.10.2 Takeda Business Overview

11.10.3 Takeda Ankylosing Spondylitis Treatment Drug Introduction

11.10.4 Takeda Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

11.10.5 Takeda Recent Development

11.11 Mitsubishi Tanabe

11.11.1 Mitsubishi Tanabe Company Details

11.11.2 Mitsubishi Tanabe Business Overview

11.11.3 Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Introduction

11.11.4 Mitsubishi Tanabe Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

11.11.5 Mitsubishi Tanabe Recent Development

11.12 Hisun Pharm

11.12.1 Hisun Pharm Company Details

11.12.2 Hisun Pharm Business Overview

11.12.3 Hisun Pharm Ankylosing Spondylitis Treatment Drug Introduction

11.12.4 Hisun Pharm Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

11.12.5 Hisun Pharm Recent Development

11.13 Guojian Pharmaceutical

11.13.1 Guojian Pharmaceutical Company Details

11.13.2 Guojian Pharmaceutical Business Overview

11.13.3 Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Introduction

11.13.4 Guojian Pharmaceutical Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

11.13.5 Guojian Pharmaceutical Recent Development

11.14 Bio-Thera Solutions

11.14.1 Bio-Thera Solutions Company Details

11.14.2 Bio-Thera Solutions Business Overview

11.14.3 Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Introduction

11.14.4 Bio-Thera Solutions Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

11.14.5 Bio-Thera Solutions Recent Development

11.15 Maibo Pharma

11.15.1 Maibo Pharma Company Details

11.15.2 Maibo Pharma Business Overview

11.15.3 Maibo Pharma Ankylosing Spondylitis Treatment Drug Introduction

11.15.4 Maibo Pharma Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

11.15.5 Maibo Pharma Recent Development

11.16 Celgen Pharm

11.16.1 Celgen Pharm Company Details

11.16.2 Celgen Pharm Business Overview

11.16.3 Celgen Pharm Ankylosing Spondylitis Treatment Drug Introduction

11.16.4 Celgen Pharm Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

11.16.5 Celgen Pharm Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abbott

Merck

Eisai Co Ltd

Novartis

Pfizer Inc

Johson & Johson

Abbive

UCB

Amgen Inc

Takeda

Mitsubishi Tanabe

Hisun Pharm

Guojian Pharmaceutical

Bio-Thera Solutions

Maibo Pharma

Celgen Pharm

List of Tables

Table 1. Global Ankylosing Spondylitis Treatment Drug Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Non-steroidal Anti-inflammatory Drugs

Table 3. Key Players of Inhibitor

Table 4. Global Ankylosing Spondylitis Treatment Drug Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Ankylosing Spondylitis Treatment Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Ankylosing Spondylitis Treatment Drug Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Ankylosing Spondylitis Treatment Drug Market Share by Region (2020-2025)

Table 8. Global Ankylosing Spondylitis Treatment Drug Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Ankylosing Spondylitis Treatment Drug Market Share by Region (2026-2031)

Table 10. Ankylosing Spondylitis Treatment Drug Market Trends

Table 11. Ankylosing Spondylitis Treatment Drug Market Drivers

Table 12. Ankylosing Spondylitis Treatment Drug Market Challenges

Table 13. Ankylosing Spondylitis Treatment Drug Market Restraints

Table 14. Global Ankylosing Spondylitis Treatment Drug Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Ankylosing Spondylitis Treatment Drug Market Share by Players (2020-2025)

Table 16. Global Top Ankylosing Spondylitis Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ankylosing Spondylitis Treatment Drug as of 2024)

Table 17. Ranking of Global Top Ankylosing Spondylitis Treatment Drug Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Ankylosing Spondylitis Treatment Drug Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Ankylosing Spondylitis Treatment Drug, Headquarters and Area Served

Table 20. Global Key Players of Ankylosing Spondylitis Treatment Drug, Product and Application

Table 21. Global Key Players of Ankylosing Spondylitis Treatment Drug, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Ankylosing Spondylitis Treatment Drug Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Ankylosing Spondylitis Treatment Drug Revenue Market Share by Type (2020-2025)

Table 25. Global Ankylosing Spondylitis Treatment Drug Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Ankylosing Spondylitis Treatment Drug Revenue Market Share by Type (2026-2031)

Table 27. Global Ankylosing Spondylitis Treatment Drug Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Ankylosing Spondylitis Treatment Drug Revenue Market Share by Application (2020-2025)

Table 29. Global Ankylosing Spondylitis Treatment Drug Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Ankylosing Spondylitis Treatment Drug Revenue Market Share by Application (2026-2031)

Table 31. North America Ankylosing Spondylitis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Ankylosing Spondylitis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Ankylosing Spondylitis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Ankylosing Spondylitis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Ankylosing Spondylitis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Ankylosing Spondylitis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Ankylosing Spondylitis Treatment Drug Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Ankylosing Spondylitis Treatment Drug Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Ankylosing Spondylitis Treatment Drug Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Ankylosing Spondylitis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Ankylosing Spondylitis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Ankylosing Spondylitis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size by Country (2026-2031) & (US$ Million)

Table 46. Abbott Company Details

Table 47. Abbott Business Overview

Table 48. Abbott Ankylosing Spondylitis Treatment Drug Product

Table 49. Abbott Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025) & (US$ Million)

Table 50. Abbott Recent Development

Table 51. Merck Company Details

Table 52. Merck Business Overview

Table 53. Merck Ankylosing Spondylitis Treatment Drug Product

Table 54. Merck Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025) & (US$ Million)

Table 55. Merck Recent Development

Table 56. Eisai Company Details

Table 57. Eisai Business Overview

Table 58. Eisai Ankylosing Spondylitis Treatment Drug Product

Table 59. Eisai Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025) & (US$ Million)

Table 60. Eisai Recent Development

Table 61. Novartis Company Details

Table 62. Novartis Business Overview

Table 63. Novartis Ankylosing Spondylitis Treatment Drug Product

Table 64. Novartis Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025) & (US$ Million)

Table 65. Novartis Recent Development

Table 66. Pfizer Company Details

Table 67. Pfizer Business Overview

Table 68. Pfizer Ankylosing Spondylitis Treatment Drug Product

Table 69. Pfizer Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025) & (US$ Million)

Table 70. Pfizer Recent Development

Table 71. Johson & Johson Company Details

Table 72. Johson & Johson Business Overview

Table 73. Johson & Johson Ankylosing Spondylitis Treatment Drug Product

Table 74. Johson & Johson Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025) & (US$ Million)

Table 75. Johson & Johson Recent Development

Table 76. Abbive Company Details

Table 77. Abbive Business Overview

Table 78. Abbive Ankylosing Spondylitis Treatment Drug Product

Table 79. Abbive Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025) & (US$ Million)

Table 80. Abbive Recent Development

Table 81. UCB Company Details

Table 82. UCB Business Overview

Table 83. UCB Ankylosing Spondylitis Treatment Drug Product

Table 84. UCB Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025) & (US$ Million)

Table 85. UCB Recent Development

Table 86. Amgen Company Details

Table 87. Amgen Business Overview

Table 88. Amgen Ankylosing Spondylitis Treatment Drug Product

Table 89. Amgen Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025) & (US$ Million)

Table 90. Amgen Recent Development

Table 91. Takeda Company Details

Table 92. Takeda Business Overview

Table 93. Takeda Ankylosing Spondylitis Treatment Drug Product

Table 94. Takeda Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025) & (US$ Million)

Table 95. Takeda Recent Development

Table 96. Mitsubishi Tanabe Company Details

Table 97. Mitsubishi Tanabe Business Overview

Table 98. Mitsubishi Tanabe Ankylosing Spondylitis Treatment Drug Product

Table 99. Mitsubishi Tanabe Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025) & (US$ Million)

Table 100. Mitsubishi Tanabe Recent Development

Table 101. Hisun Pharm Company Details

Table 102. Hisun Pharm Business Overview

Table 103. Hisun Pharm Ankylosing Spondylitis Treatment Drug Product

Table 104. Hisun Pharm Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025) & (US$ Million)

Table 105. Hisun Pharm Recent Development

Table 106. Guojian Pharmaceutical Company Details

Table 107. Guojian Pharmaceutical Business Overview

Table 108. Guojian Pharmaceutical Ankylosing Spondylitis Treatment Drug Product

Table 109. Guojian Pharmaceutical Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025) & (US$ Million)

Table 110. Guojian Pharmaceutical Recent Development

Table 111. Bio-Thera Solutions Company Details

Table 112. Bio-Thera Solutions Business Overview

Table 113. Bio-Thera Solutions Ankylosing Spondylitis Treatment Drug Product

Table 114. Bio-Thera Solutions Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025) & (US$ Million)

Table 115. Bio-Thera Solutions Recent Development

Table 116. Maibo Pharma Company Details

Table 117. Maibo Pharma Business Overview

Table 118. Maibo Pharma Ankylosing Spondylitis Treatment Drug Product

Table 119. Maibo Pharma Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025) & (US$ Million)

Table 120. Maibo Pharma Recent Development

Table 121. Celgen Pharm Company Details

Table 122. Celgen Pharm Business Overview

Table 123. Celgen Pharm Ankylosing Spondylitis Treatment Drug Product

Table 124. Celgen Pharm Revenue in Ankylosing Spondylitis Treatment Drug Business (2020-2025) & (US$ Million)

Table 125. Celgen Pharm Recent Development

Table 126. Research Programs/Design for This Report

Table 127. Key Data Information from Secondary Sources

Table 128. Key Data Information from Primary Sources

Table 129. Authors List of This Report

List of Figures

Figure 1. Ankylosing Spondylitis Treatment Drug Picture

Figure 2. Global Ankylosing Spondylitis Treatment Drug Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Ankylosing Spondylitis Treatment Drug Market Share by Type: 2024 VS 2031

Figure 4. Non-steroidal Anti-inflammatory Drugs Features

Figure 5. Inhibitor Features

Figure 6. Global Ankylosing Spondylitis Treatment Drug Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Ankylosing Spondylitis Treatment Drug Market Share by Application: 2024 VS 2031

Figure 8. Hospital Pharmacy Case Studies

Figure 9. Retail Pharmacy Case Studies

Figure 10. Online Pharmacy Case Studies

Figure 11. Other Case Studies

Figure 12. Ankylosing Spondylitis Treatment Drug Report Years Considered

Figure 13. Global Ankylosing Spondylitis Treatment Drug Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Ankylosing Spondylitis Treatment Drug Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Ankylosing Spondylitis Treatment Drug Market Share by Region: 2024 VS 2031

Figure 16. Global Ankylosing Spondylitis Treatment Drug Market Share by Players in 2024

Figure 17. Global Top Ankylosing Spondylitis Treatment Drug Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Ankylosing Spondylitis Treatment Drug as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Ankylosing Spondylitis Treatment Drug Revenue in 2024

Figure 19. North America Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Ankylosing Spondylitis Treatment Drug Market Share by Country (2020-2031)

Figure 21. United States Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Ankylosing Spondylitis Treatment Drug Market Share by Country (2020-2031)

Figure 25. Germany Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Ankylosing Spondylitis Treatment Drug Market Share by Region (2020-2031)

Figure 33. China Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Ankylosing Spondylitis Treatment Drug Market Share by Country (2020-2031)

Figure 41. Mexico Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Ankylosing Spondylitis Treatment Drug Market Share by Country (2020-2031)

Figure 45. Turkey Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Ankylosing Spondylitis Treatment Drug Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Abbott Revenue Growth Rate in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

Figure 49. Merck Revenue Growth Rate in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

Figure 50. Eisai Revenue Growth Rate in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

Figure 51. Novartis Revenue Growth Rate in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

Figure 52. Pfizer Revenue Growth Rate in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

Figure 53. Johson & Johson Revenue Growth Rate in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

Figure 54. Abbive Revenue Growth Rate in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

Figure 55. UCB Revenue Growth Rate in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

Figure 56. Amgen Revenue Growth Rate in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

Figure 57. Takeda Revenue Growth Rate in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

Figure 58. Mitsubishi Tanabe Revenue Growth Rate in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

Figure 59. Hisun Pharm Revenue Growth Rate in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

Figure 60. Guojian Pharmaceutical Revenue Growth Rate in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

Figure 61. Bio-Thera Solutions Revenue Growth Rate in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

Figure 62. Maibo Pharma Revenue Growth Rate in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

Figure 63. Celgen Pharm Revenue Growth Rate in Ankylosing Spondylitis Treatment Drug Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Spine Disorders Treatment Market Research Report 2024

Back and Spine Pain Treatment Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatic Disorders Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Musculoskeletal Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Neck Pain Treatment Solutions Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Arthritis Pain Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Orthopedics Nonsteroidal Anti Inflammatory Drugs NSAIDs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Uveitis Treatment Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Rheumatology Arthritis Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Inflammatory Bowel Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Psoriatic Arthritis Treatment Drugs Market Research Report 2025

Scleroderma Diagnostics and Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Scleroderma Treatment Market Research Report 2025

Aneurysm Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lumbar Therapy Instrument Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Psoriatic Arthritis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Insulin Coolers Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-19Z7671

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Ossicular Prostheses Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10V14317

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Defibrillator Accessories Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-10O5919

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

Global Septicemia Diagnostic Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-4I19963

Thu Sep 18 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions